Top 3 Health Care Stocks That Are Set To Fly This Quarter
Top 3 Health Care Stocks That Are Set To Fly This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
醫療保健板塊中最超賣的股票爲買入被低估的公司提供了機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI指標是一種動量指標，它比較了股票在價格上漲時的強度與在價格下跌時的強度。與股票的價格走勢進行比較，可以給交易者更好的了解股票短期內表現的良好程度。當RSI低於30時，資產通常被認爲是超賣的，根據Benzinga Pro的數據。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是本行業板塊最近的主要超賣股票列表，RSI接近或低於30。
BIMI Holdings Inc (NASDAQ:BIMI)
BIMI控股有限公司（納斯達克：BIMI）
- On May 20, BIMI announced the receipt of a delinquency compliance alert notice from Nasdaq. The company's stock fell around 68% over the past five days and has a 52-week low of $0.24.
- RSI Value: 24.62
- BIMI Price Action: Shares of BIMI Holdings closed at $0.42 on Wednesday.
- Benzinga Pro's charting tool helped identify the trend in DXCM stock.
- 5月20日，BIMI宣佈收到納斯達克的不合規警示通知。該公司股價在過去5天內下跌了約68％，52周內最低價爲0.24美元。
- RSI值：24.62
- BIMI控股股票週三收盤價爲0.42美元。
- Benzinga Pro的圖表工具幫助識別DXCm股票的趨勢。
Edwards Lifesciences Corp (NYSE:EW)
愛德華生命科學公司（紐約證券交易所：EW）
- On July 24, Edwards Lifesciences reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.. The company's stock fell around 30% over the past month. It has a 52-week low of $58.93.
- RSI Value: 22.55
- EW Price Action: Shares of Edwards Lifesciences closed at $63.05 on Wednesday.
- Benzinga Pro's real-time newsfeed alerted to latest EW news.
- 7月24日，愛德華生命科學公司報告第二季度銷售收入低於預期，併發出低於預期的第三季度指導。此外，該公司收購了JenaValve和Endotronix。該公司股價在過去一個月內下跌了約30％，52周最低價爲58.93美元。
- RSI值：22.55
- 愛德華生命科學股票週三收盤價爲63.05美元。
- Benzinga Pro的實時新聞提醒了最新的愛德華生命科學資訊。
Merck & Co Inc (NYSE:MRK)
默克（紐約證券交易所：MRK）
- Merck reported better-than-expected second-quarter earnings and sales results on Tuesday. The company posted quarterly sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15. The company's shares fell around 12% over the past month and has a 52-week low of $99.14.
- RSI Value: 28.20
- MRK Price Action: Shares of Merck rose 0.1% to close at $113.13 on Wednesday.
- 默克公司週二報告了超出市場預期的第二季度盈利和銷售業績。該公司發佈了161億美元的季度銷售額，同比增長了7％，超過了市場預期的158.4億美元。不計入外匯影響，銷售額增長了11％。默克公司報告了每股調整後的盈利爲2.28美元，而不是預期的每股收益虧損2.06美元，超過市場預期的2.15美元。該公司股價在過去一個月內下跌了約12％，52周最低價爲99.14美元。
- RSI值：28.20
- 默沙東股票週三上漲了0.1％，收於113.13美元。
Read More:
閱讀更多：
- Nasdaq Settles Higher As Nvidia Records Best Session Since February: Fear & Greed Index Now In 'Neutral' Zone As Investor Sentiment Improves
- 納斯達克收盤於較高點，英偉達創下自2月以來的最佳交易日：恐懼與貪婪指數現處於"中立"區域，投資者情緒得到改善。
譯文內容由第三人軟體翻譯。
